Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapy.

Shiro WatanabeShozo OkamotoKazumasa AkikawaNoriyuki MiyamotoMiyuki Okamura-KawasakiYuko UchiyamaJunki TakenakaTakuya ToyonagaKenji HirataKohsuke Kudo

Published in: Annals of nuclear medicine (2022)

Although the overall remission rate was not significantly different between the patients who received high- or low-dose I-131, treatment with high-dose RAI may improve the probability of remission in patients with a massive thyroid volume and/or high-TSAb Graves' disease.

Keyphrases

high dose
low dose
stem cell transplantation
disease activity
stem cells
magnetic resonance imaging
combination therapy